Alain Micaleff

Alain Micaleff currently serves as a Senior Medical Safety Advisor at Merck Serono, where he leverages over three decades of extensive experience in the pharmaceutical industry, with a specialized focus on pharmacovigilance, medical safety, and risk management. In his role, Alain provides critical medical advice across all aspects related to benefit-risk assessment and safety profile evaluation, ensuring that the company’s development and marketed products maintain optimal safety and efficacy standards. His expertise encompasses the entire clinical development process, from early-phase trials through regulatory submission and lifecycle management, enabling him to support robust pharmacovigilance activities and compliance with global safety regulations.

A key contributor to Merck Serono’s safety and risk management strategies, Alain plays a pivotal role in risk modeling and benefit-risk balance assessments, employing advanced concepts and modeling techniques to inform decision-making processes. His involvement as a co-leader of Work Package 5 within the PROTECT project underscores his leadership in innovative benefit-risk modeling initiatives, which aim to enhance the predictive accuracy of safety profiles and optimize benefit-risk trade-offs for complex therapeutic areas.

Alain’s multidisciplinary and multicultural background allows him to collaborate effectively with cross-functional teams, including clinical development, regulatory affairs, and medical affairs, fostering a comprehensive approach to pharmacovigilance. His deep knowledge of Good Clinical Practice (GCP), combined with his skills in benefit-risk assessment concepts and risk management, positions him as a trusted expert in ensuring patient safety and regulatory compliance throughout the product lifecycle. As a strategic partner to the Chief Medical Officer, Alain’s insights support critical decision-making processes that impact the safety and success of Merck Serono’s portfolio.